Chemed Co. (NYSE:CHE) Shares Sold by North Point Portfolio Managers Corp OH

North Point Portfolio Managers Corp OH reduced its holdings in shares of Chemed Co. (NYSE:CHE) by 1.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 16,272 shares of the company’s stock after selling 269 shares during the period. North Point Portfolio Managers Corp OH’s holdings in Chemed were worth $8,621,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. International Assets Investment Management LLC purchased a new stake in shares of Chemed during the third quarter worth $437,150,000. FMR LLC increased its holdings in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after purchasing an additional 45,917 shares during the period. Thrivent Financial for Lutherans raised its position in Chemed by 25.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company’s stock valued at $87,752,000 after purchasing an additional 29,445 shares in the last quarter. Aureus Asset Management LLC boosted its stake in shares of Chemed by 3,147.2% in the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company’s stock valued at $17,993,000 after buying an additional 29,017 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Chemed by 143.5% during the third quarter. Allspring Global Investments Holdings LLC now owns 42,267 shares of the company’s stock worth $25,401,000 after buying an additional 24,912 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

NYSE:CHE opened at $550.99 on Monday. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62. The stock has a market cap of $8.29 billion, a P/E ratio of 27.84, a P/E/G ratio of 2.15 and a beta of 0.47. The stock has a 50-day simple moving average of $544.24 and a 200-day simple moving average of $563.47.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. During the same period last year, the company earned $5.32 earnings per share. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, equities research analysts predict that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed’s dividend payout ratio is currently 10.11%.

Insider Activity at Chemed

In other news, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction on Monday, December 30th. The stock was bought at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 732 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. This trade represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CHE has been the topic of several analyst reports. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.